Search:
(clear)
- Alpha Test
- App
- Architecture
- Artificial Intelligence
- Beta Test
- Big Data
- Biologics
- Biomarker
- BLA
- Clinical Decision Support
- Clinical Development
- CMS
- Combination Product
- Compliance
- Device
- Diagnostic
- Digital Healthcare
- Disease Management
- DRGs
- Drug
- EMA
- FDA
- LIMS
- Machine Learning
- MDDS
- mHealth
- NDA
- Payer
- Personalized Medicine
- Phase I Trial
- Phase II Trials
- Phase III Trials
- Phase IV Trials
- Picture Archiving (PICS)
- PMA
- Polymorphism
- Population Health
- Precision Medicine
- Provider
- Quantified Self
- SaaS
- Sequence
- SNP
- Telehealth
- Translational Medicine
- UX
A New Drug Application: The comprehensive document submitted by a drug manufacturer to the FDA seeking approval for the commercial deployment of a drug or, colloquially, receipt of approval. NDAs are typically thousands of pages in length and detail the results of years of study on the underlying pharmacology, chemistry, manufacturing methods, analytics, safety, preclinical science and clinical efficacy of the new drug.